Indian Insulin Market Size

Share on facebook

Cancer tattoo designs Video link: https://youtu.be/ff9f0UJwADo The scourge that is cancer leaves no one untouched. Along with the people who get the disease, the families of those afflicted also suffer from the terrible pain that cancer can inflict. That is why the ribbons that are worn to show their awareness of the disease or as a tribute to those who suffered cancer or as a mark of victory over the disease is an especially meaningful tattoo. People often have a cancer ribbon tattooed for many reasons. These come in different colors and each color has its own importance. Both men and women get these tattoos as their own personal badge for having faced this disease either directly or indirectly. These ribbon tattoos that are worn by cancer patients and people who survived the disease as well as the any who are associated with this disease definitely looks good. But that is not at all the point of these ribbon tattoos. They are worn to show love, compassion, honor, encourage and strengthen the fight against this dreaded disease. People want others to be aware of the disease, be on the lookout for this disease, not to lose hope once they discover they are afflicted and are meant to

Idc Designs Insulin Pens For Indian Market

Award winning product designer, Industrial Design Consultancy Ltd (IDC), has just completed a project to develop both disposable and reusable insulin pens for Indian consumers. The resulting products are expected to dramatically advance diabetes treatment in India, by offering a portable, discreet, quick and easy insulin dosage system for users on the move. Indian company, Wockhardt, was keen to introduce affordable disposable and reusable insulin pens to Indian healthcare but the patent restrictions on existing designs were such that they were unable to cost-effectively go into production. In order to overcome this, Wockhardt contracted IDC to design a completely new insulin pen, which would give class-leading functionality and avoid all the existing patents. Virtually all elements of the conventional insulin pens were patented, so IDC was challenged to find successful design alternatives, which also resulted in an improved product. It was important that the insulin pens were designed to be compact and discreet, with an easy dosing facility for people with vision or dexterity problems. IDC’s in-house engineers worked closely with its product designers to ensure that use-ability Continue reading >>

Share on facebook

Popular Questions

  1. spakesneaker

    What does it mean if, in a blood test, insulin is high but glucose levels are normal? Doesn't this mean that a person's cells might be resistant to insulin?
    I ask because I had an extremely frustrating doctor's appointment today where the doctor looked over my blood test results from a few years ago when I was diagnosed as PCOS and insulin resistant. She said that because my glucose levels are normal (and I don't have problems with blood pressure or triglycerides), I don't have insulin resistance--she also said that fasting insulin is meaningless as a test, and that it doesn't really tell us anything medically.
    I know that my glucose levels are normal, but I have no idea what my base insulin levels are like these days (although I'm sure that with primal they're a lot better than they used to be), because doctors don't seem to find it a valuable test to run on someone who previously had ridiculously high insulin levels.
    WTF?? Someone please explain this to me. Did I just go to an incredibly stupid doctor, who won't recommend any treatment other than "continue losing weight, and eat more fruits and vegetables" unless a patient's hyperinsulinemia progresses to type 2 diabetes??

  2. AndreaReina

    Have they done a glucose tolerance test (drink a glucose solution, see how long it takes for BS to fall)? If both fasting glucose and glucose tolerance show good results I imagine you should be fine, since the problem with insulin resistance is that it results in chronically elevated BS. I don't really know what an insulin test would show independently of glucose, but this isn't something I've researched a lot, sorry.

  3. O_O

    Did your doctor do a HbA1C and a fasting glucose test?

  4. -> Continue reading
read more
Share on facebook

India Becomes 4th Largest Market For Sony

Japanese consumer electronics giant Sony on Wednesday said its Indian operations have emerged as its fourth largest globally, overtaking businesses in Brazil and Russia by the end of December quarter this fiscal. The sluggish demand in developed nations has helped the company’s growing subsidiary Sony India, which has clocked a revenue of over Rs 6,000 crore during April-December period in 2012-13, to improve its position in global ranking. “The Indian operations has become the number four in global ranking. We have overtaken Brazil and Russia, which were ahead of us in last fiscal,” Sony India Managing Director Kenichiro Hibi told reporters in Las Vegas. The existing top three positions are held by the US, China and Japan, he said without sharing details. “We have almost touched last year’s revenue... We are completely on our track to treble our turnover to Rs 20,000 crore by 2015,” Mr. Hibi said. The Indian operations’ revenue for 2011-12 was Rs 6,313 crore compared to Rs 5,446 crore in the previous fiscal. The company is expecting 30-40 per cent growth in this fiscal. Sony India’s achievement comes at a time when its parent is reporting losses due to unfavourable Continue reading >>

Share on facebook

Popular Questions

  1. shroomysoup

    Can someone help me with these insulin products and make sure that I got the ingredients down correctly? Also, what is the difference between Humulin 70/30 and Humulin 50/50? What is the difference between Humalog Mix 75/25 and Humalog Mix 50/50?
    Humulin 70/30 - intermediate-acting (human insulin isophane) + short-acting (regular)
    Humulin 50/50 - same as Humulin 70/30 except 50/50?
    Novolin 70/30 - NPH 70%, Regular 30%
    Humalog Mix 75/25 - intermediate-acting (lispro protamine) + rapid-acting
    Humalog Mix 50/50 - same as above except 50/50?
    Novolog Mix 70/30 - rapid-acting? (aspart protamine 70%, aspart 30%)

  2. fenixtnlfan

    The 70/30, 50/50 refers to the concentration of each ingredient. Example: Humulin 70/30 is 70% isophane and 30% regular insulin. I'm sure a quick Google search would confirm the different insulin ingredients. I don't know all those yet.

  3. shroomysoup

    fenixtnlfan said: ↑
    The 70/30, 50/50 refers to the concentration of each ingredient. Example: Humulin 70/30 is 70% isophane and 30% regular insulin. I'm sure a quick Google search would confirm the different insulin ingredients. I don't know all those yet. Yeah, I know that. I just want to know what the advantages are between 70/30 and 50/50. And what is the difference between aspart protamine and aspart?

  4. -> Continue reading
read more
Share on facebook

Skillsoft's Leadership Development Program (SLDP) provides the format that is most successful for leadership development: engaging, scenario-based, contextual content. Both behavior demonstration and scenario-based approaches to leadership training are highly engaging and effective. "As digital transformation impacts every organization, its critical that leaders at all levels are prepared and possess the competencies needed to harness and drive innovation, said Heide Abelli, Senior Vice President of Content Product Management, Skillsoft. This learning solution addresses the changing way in which organizations need to develop their leaders by providing a scalable, cost-effective, and engaging leadership development experience designed for the modern, digital learner. SLDP is unique in the market because 1) all of the learning is behavioral demonstration in nature. 2) All learning is set within the team context leaders manage teams we need to teach the content in the context of how leaders actually operate. 3) The scenarios are pragmatic and tackle modern leadership dilemmas in the digital age. To learn more about SLDP, please visit: http://ow.ly/wScx50hOzS9 Visit our website: http

3. Biogenerics-need For Regulatory Development In India

Palleti Lakshmi Prathusha N. Vishal Gupta* Pharmaceutical Quality Assurance Group, Department of Pharmaceutics, JSS College of Pharmacy, JSS University, Shri Shivarathreeshwara Nagar, Mysore-570015, Karnataka, India Corresponding Author: N. Vishal Gupta Dept. of Pharmaceutics, JSS College of Pharmacy, Shri Shivarathreeshwara Nagar, Mysore - 570 015, Karnataka, India; E-mail: [email protected] Date of Submission: 18-05-2013 Date of Acceptance: 29-05-2013 Conflict of Interest: NIL Source of Support: NONE Copyright: © 2013 N. Vishal Gupta et al, publisher and licensee IYPF. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. Related article at Pubmed, Scholar Google Visit for more related articles at International Journal of Drug Development and Research First-generation biopharmaceuticals have come off patent or lose marketing exclusivity. This has paved the way for the manufacture of generic biopharmaceuticals which are otherwise called as biogenerics. According to estimation, biologic drugs worth more than $80 billion in global sales will lose patent protection by the year 2015, presenting a major opportunit Continue reading >>

Share on facebook

Popular Questions

  1. CharleyBee

    Hi! I'm 36 weeks pregnant and using a ton of insulin, which means buying insulin more frequently and at $140 for a box of five humalog pens, it's getting hard for me to afford. My levemir costs about the same, a little less. I have United Healthcare through my husband's job. I've tried using those co-pay savings cards but they don't work (I use the Walmart pharmacy). Every time I refill my prescriptions, the price always increases by at least ten dollars...I'm scared I'm eventually not going to be able to afford my meds. Does anybody have any tips on how I could get my humalog (or anything that works the same) & levemir/lantus any cheaper? Thank you!!

  2. CharleyBee

    thanks! UHC does cover my insulin, or at least from what I understand, otherwise it would be round $700 if not more, I believe. My endo actually did increase my prescription quantity, but that doesn't change to price.

  3. auntlisa1103

    Does the rx coverage you have through UHC offer a mail order option? Mine does and you get three months worth for one copay instead of three.

  4. -> Continue reading
read more

No more pages to load

Related Articles

  • Us Insulin Market Size

    37%37%37%37%26%26%42%42%32%32%26%26% About this statistic Show source Statistics on "U.S. pharmaceutical industry" Statista for Your Company: The Research and Analysis Tool Further Content: Statistics, Studies, and Topic Pages ...

    insulin Apr 30, 2018
  • Indian Diabetes Market Size

    Pharma giants ready to harness diabetes market India has a population of nearly 65 million diabetics and 77 million pre-diabetics Last Updated at September 9, 2013 03:09 IST Novo Nordisk to launch insulin variant in India Sharma says govt looking at concerns over FDI in pharma Sensex gains over 200 pts led by FMCG & metal shares Nifty trading above 5,500 mark, financials gain Sun Pharma gains as Taro inks drug pact India has seen the entry of mo ...

    diabetes Apr 27, 2018
  • Continuous Glucose Monitoring Market Size

    Blood Glucose Monitoring System Market is expected to reach USD 13.6 Billion by 2026 from USD 8.4 Billion in 2016 at a CAGR of 4.92% (Detailed analysis of the market CAGR is provided in the report). Testing of blood sugar level is one of the best ways to understand diabetes and how different foods, medications, and activities affecting diabetes. Portable blood glucose meters, called glucometers are largely used to check blood sugar levels. These ...

    insulin Apr 11, 2018
  • Insulin Market Size In India

    Industry Insights Insulin is a hormone which facilitates the entry of glucose into the blood cells. The body’s inability to produce appropriate amount of insulin leads to accumulation of sugar in the blood stream leading to a rise in blood sugar levels and eventually diabetes. Growing global prevalence of diabetes and the increasing incidence rates of lifestyle induced disorders such as obesity are expected to drive market growth over the next ...

    insulin Apr 26, 2018
  • Indian Insulin Market Size

    Indian pharma company, Lupin Limited announced a strategic distribution agreement with LG Life Sciences of South Korea to launch Insulin Glargine, a novel insulin analogue under the brand name Basugine™. According to the agreement, Lupin would be responsible for marketing and sales of Basugine™ in India. The overall diabetes market size within the Indian pharmaceutical market stood at Rs. 6032 Crore growing at 18% (IMS MAT April 2014). The to ...

    insulin Mar 1, 2018
  • Global Insulin Market Size

    Global Insulin Market Size Is Expected To Reach $53.04 Billion By 2020 Research Analyst at Grand View Research, Inc. The global insulin market size is expected to reach USD 53.04 billion by 2022, according to a new report published by Grand View Research, Inc. The rising prevalence of diabetes and obesity and extensive R&D development forming a strong product pipeline is estimated to promote the insulin industry over the forecast period. Growing ...

    insulin Apr 30, 2018

Popular Articles

More in insulin